Precision Public Health for the Era of Precision Medicine

Precision Public Health for the Era of Precision Medicine

Muin J. Khoury, MD, PhD,1,2 Michael F. Iademarco, MD, MPH,1,3 and William T. Riley, PhD2

Author information ► Copyright and License information ► Disclaimer

The publisher's final edited version of this article is available at Am J Prev Med

See commentary "Informing Future Population Health Interventions" in Cancer Epidemiol Biomarkers Prev, volume 25 on page 583.

See other articles in PMC that cite the published article.

The Precision Medicine Initiative1 promises a new healthcare era. A proposed 1 million—person cohort could create a deeper understanding of disease causation. Improvements in quality of sequencing, reduction in price, and advances in “omic” fields and biotechnology promise a new era, variably labeled personalized or precision medicine. Although genomics is one driver of precision health care, other factors may be as important (e.g., health information technology).